Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

HIGH Altitude CArdiovascular REsearch in the ANDES

Trial Profile

HIGH Altitude CArdiovascular REsearch in the ANDES

Completed
Phase of Trial: Phase IV

Latest Information Update: 04 Sep 2013

At a glance

  • Drugs Nifedipine (Primary) ; Telmisartan (Primary)
  • Indications Hypertension
  • Focus Therapeutic Use
  • Acronyms HIGH CARE ANDES
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 04 Sep 2013 Results presented at the ESC Congress 2013: Annual Congress of the European Society of Cardiology.
    • 04 Sep 2013 Primary endpoint 'Ambulatory-blood-pressure' has been met according to results presented at the ESC Congress 2013: Annual Congress of the European Society of Cardiology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top